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Background: Cognitive behaviour therapy (CBT) has been shown to be an effective treatment for anxiety
disorders in children, but few affected seek or receive treatment. Internet-delivered CBT (ICBT) could be a
way to increase the availability of empirically supported treatments.
Aims: A randomised controlled trial was conducted to evaluate ICBT for children with anxiety disorders.
Method: Families (N ¼ 93) with a child aged 8e12 years with a principal diagnosis of generalised anxiety
disorder, panic disorder, separation anxiety, social phobia or speciﬁc phobia were recruited through
media advertisement. Participants were randomised to 10 weeks of ICBT with therapist support, or to a
waitlist control condition. The primary outcome measure was the Clinician Severity Rating (CSR) and
secondary measures included child- and parent-reported anxiety. Assessments were made at pre-
treatment, post-treatment and at three-month follow-up.
Results: At post-treatment, there were signiﬁcant reductions on CSR in the treatment group, with a large
between-group effect size (Cohen's d ¼ 1.66). Twenty per cent of children in the treatment group no
longer met criteria for their principal diagnosis at post-treatment and at follow-up this number had
increased to 50%. Parent-reported child anxiety was signiﬁcantly lower in the treatment group than in
the waitlist group at post-treatment, with a small between-group effect size (Cohen's d ¼ 0.45). There
were no signiﬁcant differences between the groups regarding child-ratings of anxiety at post-treatment.
Improvements were maintained at three-month follow-up, although this should be interpreted
cautiously due to missing data.
Conclusions: Within the limitations of this study, results suggest that ICBT with therapist support for
children with anxiety disorders can reduce clinician- and parent-rated anxiety symptoms.
Trial registration: Clinicaltrials.gov: NCT01533402.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Epidemiological studies show that 5e10% of children and ado-
lescents suffer from an anxiety disorder, which means that it is one
of the most common mental disorders for this age group (Pine &
Klein, 2008). Anxiety disorders are associated with suffering andPsychiatry Research Centre,
rland), brjann.ljotsson@ki.se
psychology.su.se (L.-G. €Ost),
us@ki.se (E. Serlachius).
Ltd. This is an open access article uimpairments in everyday life of the affected individual as well as in
the family and among relatives, and increase the risk for depres-
sion, substance abuse and impairment in social and emotional
functioning during adolescence and early adulthood (Costello,
Angold, & Keeler, 1999; Fichter, Quadﬂieg, Fischer, & Kohlboeck,
2009; Ginsburg, La Greca, & Silverman, 1998; Pine & Klein, 2008).
Thus, childhood anxiety disorders should be identiﬁed and treated
as early as possible.
There is strong support for cognitive behaviour therapy (CBT) as
an effective treatment for anxiety disorders in children (James,
James, Cowdrey, Soler, & Choke, 2013), and CBT is regarded to be
the treatment of choice for this group (Dadds & Barrett, 2001).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ety disorders do not receive evidence-based psychological treat-
ment (Chavira, Stein, Bailey, & Stein, 2005; Costello, He, Sampson,
Kessler, & Merikangas, 2014). It is therefore important to ﬁnd
means to increase the availability of CBT for this population.
Computers and the Internet enable us to offer less therapist-
intensive but effective interventions over long distances, which
can increase the availability of evidence based treatments. Internet-
delivered CBT (ICBT) has proven to be an effective method in the
treatment of adults with depression and anxiety disorders
(Andersson, 2014; Hedman, Ljotsson, & Lindefors, 2012). Studies
have not only shown efﬁcacy of ICBT compared to no-treatment
control conditions, but have also demonstrated results compara-
ble to face-to-face treatment (Andersson, Cuijpers, Carlbring, Riper,
& Hedman, 2014).
To date, there are several trials evaluating computerised or
internet delivered CBT-interventions for children and adolescents
with anxious or depressive symptoms (Pennant et al., 2015; Reyes-
Portillo et al., 2014; Richardson, Stallard, & Velleman, 2010). ICBT
has some potential advantages compared to computerised CBT, the
most important being the possibility of non-synchronous therapist
support independent of geographical distances, as computerised
approaches often involve face-to face therapist support (Khanna &
Kendall, 2010; Stallard, Richardson, Velleman, & Attwood, 2011).
Wuthrich et al. (2012) conducted a RCT comparing a CD-ROM
delivered treatment with telephone-delivered therapist support
to a waitlist control for adolescents with anxiety disorders, making
it more comparable to ICBT.
A majority of the evaluated ICBT programs are prevention pro-
grams that target children and adolescents who are “at risk” or have
elevated symptom levels (Reyes-Portillo et al., 2014). The BRAVE-
ONLINE programs, however, have been evaluated for children and
adolescents with diagnosed anxiety disorders and have shown
promising results (Donovan & March, 2014; March, Spence, &
Donovan, 2009; Spence et al., 2011). For example, March et al.
(2009) compared an internet-delivered program for children
(8e12 years) with anxiety disorders to await-list control and found
a signiﬁcantly larger decrease of clinician rated anxiety severity in
the ICBT group. Results on child- and parent-rated anxiety symp-
toms were mixed at post-treatment. Reyes-Portillo et al. (2014)
considered BRAVE ONLINE to be “probably efﬁcacious” but
pointed out that the results need to be replicated by other research
groups to further increase the evidence-base level.
We have previously evaluated ICBT for children with speciﬁc
phobia in an open trial with promising results (Vigerland et al.,
2013). Although there are a few studies with promising results,
more studies are needed to establish the efﬁcacy of ICBT for chil-
dren with anxiety disorders. The aim of the present study was to
evaluate the efﬁcacy of ICBT for children with anxiety disorders
compared to a waitlist control.
2. Method
2.1. Participants
Participants were self-referred and recruited nationally in
Sweden during 2012 through media advertisement. One parent in
each family was required to be responsible for participation and to
be the primary contact with the research team when needed. In-
clusion criteria for the study were; a) children had to be 8e12 years
of age, b) have a principal diagnosis of either generalised anxiety
disorder, panic disorder, separation anxiety, social phobia or spe-
ciﬁc phobia (except for blood-injury, or injection phobia) according
to DSM-IV criteria, c) any psychotropicmedications had to be stable
for 3 months prior the treatment, and d) the family had to haveaccess to a computer and internet and speak Swedish.
Participants were excluded if the child a) had a diagnosed
neurodevelopmental disorder (e.g. autism or attention-deﬁcit/
hyperactivity disorder (ADHD)) b), was severely depressed
(deﬁned as20 on the Child Depression Inventory), or had another
acute psychiatric disorder (e.g. psychosis, suicidal ideation), or c)
was currently involved in psychological treatment. Participants
were also excluded if d) a parent had an on-going substance abuse
or if e) there was an on-going child custody dispute or abuse in the
family, or other family problems that made ICBT unsuitable. Finally,
families were excluded if f) the parent responsible for the treatment
and study participation suffered from serious psychiatric disorder.
The regional ethics committee in Stockholm approved the study.
Written informed consent was obtained from the parents and the
children gave their verbal consent to participate.
2.2. Assessments
2.2.1. Primary outcome measure
The primary outcomemeasure was the Clinician Severity Rating
(CSR) derived from the Anxiety Disorder Interview Schedule Child
and Parent version (ADIS C/P; Albano & Silverman, 1996). ADIS is a
semi-structured interview conducted with the child and parent
separately to assess diagnostic criteria according to DSM-IV
(American Psychiatric Association, 2000). The severity of each
diagnosis is assessed with the CSR on a 9-point scale (0e8). A score
of 3 or lower is considered as subclinical symptomswhereas a score
of 4 or higher means that the criteria for diagnosis, with regard to
severity, are fulﬁlled. The interviewing clinicians initially rate CSR
based on child and parent interviews separately and then agree on
a set of ﬁnal composite CSR-scores. The ADIS C/P has shown good to
excellent kappa coefﬁcients and excellent test-retest reliability
(Silverman, Saavedra, & Pina, 2001), and the concurrent validity of
the ADIS C/P has been established (Wood, Piacentini, Bergman,
McCracken, & Barrios, 2002). The telephone administration of
ADIS, conducted with one parent, has yielded good to excellent
agreement with the face-to-face administrated interview
(Lyneham & Rapee, 2005).
2.2.2. Secondary outcome measures
2.2.2.1. Children's Global Assessment Scale (CGAS). CGAS (Shaffer
et al., 1983) is used by clinicians to assess global functioning in
children (scale 0e100) and adolescents, with higher scores indi-
cating higher functioning. It has shownmoderate to excellent inter-
rater reliability, good stability over time and good concurrent as
well as discriminant validity (Bird, Canino, & Rubio-Stipec, 1987;
Lundh, Kowalski, Sundberg, Gumpert, & Landen, 2010; Shaffer
et al., 1983).
2.2.2.2. The Spence Children's Anxiety Scale (SCAS-C/P). SCAS-C
(Spence, 1998) measures six domains of anxiety; fear of physical
injury, generalised anxiety, obsessive-compulsive disorder, panic/
agoraphobia, separation anxiety and social anxiety. The question-
naire consists of 44 items that are rated on a 4-point scale. Higher
scores indicate high levels of anxiety. Six positive ﬁller items are
included in the children's scale. The internal consistency is high
(Cronbach's alpha ¼ 0.93; Spence, Barrett, & Turner, 2003). The
parent version (SCAS-P; Nauta et al., 2004) consists of 38 items,
formulated to correspond to the child version without ﬁller items,
and has shown high internal consistency. Cronbach's alpha in the
current study was 0.87 for SCAS-C and 0.81 for the parent scale.
2.2.2.3. Fear Survey schedule for children eRevised (FSSC-R C/P).
FSSC-R (Ollendick, 1983) consists of 80 items regarding fear of
speciﬁc things or situations. Each item is rated on a 3-point scale
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high internal consistency andmoderate test-retest reliability over a
3-month period. When administered to parents, the wording of the
questions was adjusted. Cronbach's alpha in the current study was
0.93 for FSSCR-C and 0.90 for the parent scale.
2.2.2.4. Penn State worry questionnaire for children (PSWQ-C).
The PSWQ-C/P (Chorpita, Tracey, Brown, Collica, & Barlow, 1997) is
an adaptation of the PSWQ for adults, consisting of 14 items
regarding worry that are rated on a 4-point scale, which has shown
good validity and reliability. When administered to parents, the
wording of the questions was adjusted. Cronbach's alpha in the
current study was 0.99 for PSWQ-C and 0.98 for the parent scale.
2.2.2.5. Separation anxiety inventory for children (SAI-C). The SAI-C
(In-Albon, Meyer, & Schneider, 2013) consists of 12 items that
investigate to what extent the child avoids different relevant situ-
ations. It has shown good validity and reliability. When adminis-
tered to parents, the wording of the questions was adjusted.
Cronbach's alpha in the current study was 0.99 for SAI-C and 0.93
for the parent scale.
2.2.2.6. Social phobia and anxiety inventory (SPAI-C/P). SPAI-C
(Beidel, Turner, & Morris, 1995) is a scale with 26 items that mea-
sures cognitive, somatic and behavioural aspects of social anxiety,
and it has shown good validity and reliability. The parent version
(Higa, Fernandez, Nakamura, Chorpita, & Daleiden, 2006) is iden-
tical to the child version, formulated to correspond to the child
version of, and has shown good internal consistency. Cronbach's
alpha in the current study was 0.97 for SPAI-C and 0.96 for the
parent scale.
2.2.2.7. Quality of Life Inventory e Child version (QOLI e C).
The original QOLI for adults (Frisch, Cornell, Villanueva, & Retzlaff,
1992) covers importance and satisfaction in 16 different life do-
mains, e.g. family, friends, occupation and society and has shown
good reliability and validity when administered in Swedish sam-
ples (Lindner, Andersson, €Ost, & Carlbring, 2013; Paunovic & €Ost,
2004). The Swedish child version contains fewer life domains
(n ¼ 10) and child adjusted life domains. The 10 domains are rated
on how important they are (0e2) and how satisﬁed the participant
is with them (3 to 3), generating a possible total score of 6 to 6.
Cronbach's alpha in the current study was 0.89.
2.2.2.8. Treatment satisfaction. Participant satisfaction was
measured in children and parents at post-treatment using the
Client Satisfaction Scale (CSS; Ollendick, 2010). It consists of 10
questions, answered on a 5 point rating scale, regarding satisfaction
of treatment outcome; e.g. change in fear, avoidance and whether
or not the participant would recommend the treatment to others.
Higher scores indicate higher satisfaction. Cronbach's alpha in the
current study was 0.75 for the child scale and 0.85 for the parent
scale.
2.2.3. Screening measures
2.2.3.1. Development and well-being assessment (DAWBA).
DAWBA (Goodman, Ford, Richards, Gatward, & Meltzer, 2000) is a
screening instrument containing an interview and questionnaires
for children and adolescents in the ages 5e17 for common mental
health disorders such as anxiety disorders, depression, ADHD,
autism and bipolar disorder. It has shown excellent discriminant
validity and acceptable concurrent validity (Goodman et al., 2000).
In the present study the internet-based version of DAWBA directed
to parents was used, containing both open ended and closed
questions.2.2.3.2. Child Depression Inventory (CDI). The CDI (Kovacs, 1985)
assesses the severity of depressive symptoms in children and ad-
olescents. It consists of 27 items graded from 0 (no symptoms) to 2
(severe symptoms). The questions cover depressed mood, self-
blame, loss of appetite, insomnia, interpersonal relationships and
school adjustment. Internal consistency in a psychiatric samplewas
good (Kovacs, 1985) and validity was found to be equivocal
although CDI scores were related to diagnoses in a psychiatric
sample. The CDI has shown good reliability in a Swedish sample
(Ivarsson, Svalander, & Litlere, 2006) and Cronbach's alpha in the
current study was 0.79.
2.2.3.3. Primary care evaluation of mental disorders (Prime-MD).
Parents’ symptoms of anxiety, depression and other psychiatric
problemswere assessedwith Prime-MD (Spitzer et al.,1994) at pre-
treatment. The self-report form of the Prime-MD used in this study
screens for depression, anxiety, alcohol problems, somatoform
disorders and eating disorders. It consists of 29 items answered
with yes/no. Two items were removed from the self-report form
(item 4 “Pains or problems during menstruation ” and item 5 “Pain
or problems during sexual intercourse”) as their content was
judged as irrelevant for the purpose of the questionnaire in the
current study. The self-report form has shown good overall sensi-
tivity when compared to a structured assessment by a mental
health professional (Spitzer et al., 1994).
2.3. Procedure
After responding to advertisement in newspapers, one parent
ﬁrst underwent a brief telephone interview to establish if basic
inclusion criteria were fulﬁlled (criteria a, c-e) and no exclusion
criteria were met (criteria a, c, e). Thereafter at least one parent
completed an internet-based screening instrument, DAWBA (to
screen for psychiatric comorbidity). The child and both parents
(except the cases where there onlywas one parent) then completed
CDI, SCAS, Prime-MD, and QOLI online. All questionnaires and self-
report measures were in Swedish. For those not meeting exclusion
criteria (b, d, f), the child and at least one parent underwent a face-
to-face assessment using the Swedish translation of the Anxiety
Disorders Interview Schedule (child and parent version; ADIS C/P)
with a research assistant or clinical psychologist. Global functioning
using CGAS was rated after the interview was completed. The
research assistants were last-year students in the Swedish ﬁve-year
clinical psychology program, with completed one-year training in
CBT. The other assessors were experienced psychologists with CBT-
training. If a principal diagnosis of generalised anxiety disorder,
panic disorder, separation anxiety, social phobia or speciﬁc phobia
was conﬁrmed (criterion b) and the family had given informed
consent, participants were included in the study and asked to
complete an additional self-report measure corresponding to their
principal diagnoses (FSSC-R, PSWQ, SAI or SPAI; no additional
measure was administered to those with a principal diagnosis of
panic disorder). Included participants were instructed to keep any
psychotropic medication constant throughout the treatment
period. Participants were then randomised to the intervention or a
waitlist control.
At post-treatment the relevant parts of the ADIS interview (di-
agnoses that had been scored 4 on CSR at pre-treatment) were
administered over the telephone. We did not consider it feasible to
interview the younger children over the telephone, and therefore
all post-and follow-up interviews were conducted with only a
parent. The interviewing research assistant or clinical psychologist,
who was not blind to treatment condition or baseline diagnoses,
then completed a CSR and CGAS for each participant. Parents and
children also completed CSS C/P, SCAS C/P, QOLI-C and the self-
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This procedure was repeated with the treatment group at three-
month follow-up (CSS was not included at this time point). Par-
ticipants in thewaitlist group received the treatment after the post-
measurement was completed.
2.4. Treatment
The intervention was developed by the research group and has
been evaluated for speciﬁc phobia with promising results
(Vigerland et al., 2013). The program focused mainly on exposure
but also included psychoeducation, coping strategies and problem
solving skills (see Table 1 for an overview of the treatment content).
For this study, the psychoeducation and examples in the program
was adapted into ﬁve slightly different versions to ﬁt each principal
anxiety disorder (generalised anxiety disorder, panic disorder,
separation anxiety, social phobia and speciﬁc phobia). Furthermore,
rationale and instruction for worry-timewere included in the GAD-
version included and brief psychoeducation on social skills training
was added to the social phobia version.
Participants had access to the treatment platform for ten weeks
and treatment content was presented in 11 chapters or modules
(see Table 1). The content was presented in a varied manner with
reading material, ﬁlms, animations, illustrations, and exercises (see
Figs. 1 and 2 for an example). The treatment can be described as a
combined parent-child intervention with seven of the modules
aimed at the parent(s), containing information and instructions on
how to help their child, and four modules addressed to the child.
Parents were to workwith their modules ﬁrst so that theywould be
prepared to assist their child on the child directed modules. Child
directed content was a shorter version of the parent directed in-
formation, adapted to an appropriate level and including less text
and more animations. Throughout the treatment participants had
online contact with an assigned psychologist/CBT-therapist
through written messages and written feedback on worksheets.
Families received individually tailored replies from their therapist
within 48 h after submitting exercises and/or questions. Three
telephone calls were scheduled during treatment (at the beginning,
middle and end of treatment), and additional telephone calls were
conducted if it was deemed necessary in order to increase moti-
vation or problem solve during the exposure focused weeks. The
role of the psychologist was to answer questions and clarify treat-
ment content, increase motivation and to help solve problems if
necessary.
Parents and children worked through the modules at their own
pace. They were encouraged to cover psychoeducation and ratio-
nale for exposure for both parents and children during the ﬁrst two
weeks, and then to engage in exposure for the main part of theTable 1
Overview of treatment content.
Week Module Content
1e2 1 Psychoeducation on emotions, fear and anxiety
2 Psychoeducation on anxiety disorders and CBT
3 Psychoeducation on goals and exposure hierarchies
4 An introduction to exposure, coping techniques (e.g. breathing and relax
programs)
5 An introduction to using a reward system
6 Preparation for managing obstacles
2e3 7 Psychoeducation on fear and anxiety
8 Psychoeducation on exposure, setting goals and creating exposure hier
9 Planning exposures and coping techniques (e.g. breathing and relaxatio
4e9 None Families are instructed to work on their own with exposure exercises a
10 10 Problem solving, maintenance plan
11 Summary, follow-up on goals, maintenance plantreatment. No new modules were presented during the weeks
focussing on exposure but families were instructed to log in to the
platform and report their progress. Participants were then
instructed to complete the last modules covering maintenance of
treatment progress, continued improvement, and relapse preven-
tion during the ﬁnal treatment week.
2.4.1. Statistical analyses
The power calculation was originally conducted based on an
estimated between group effect size of 0.5 (based on March et al.
(2009), d ¼ 0.56). Allowing for approximately 15% dropout, it was
estimated that 120 participants were needed (Kazdin, 2010).
However, only 93 participants were included in the trial, which led
to 80% power to detect an effect size of 0.60, with an alpha-level of
0.05 (Kazdin, 2010).
All statistics were calculated using SPSS version 22. The differ-
ence in change between the treatment group and waitlist group
from pre-to post-treatment (i.e., the group * time interaction effect)
were analysedwith hierarchical linear mixed-models (HLMM), that
used all available data without excluding cases with missing data
(Gueorguieva & Krystal, 2004). The inclusion of random intercept,
random slopes and covariance structures for repeated measures
were determined analytically using log likelihood ratio test.
Maintenance of improvement from post-treatment to follow-up for
the intervention group was tested with paired t-tests based on
observed data (i.e., no imputations of missing values were made).
Between-group effect sizes (Cohen's d) at post-treatment were
calculated based on the estimates obtained in the HLMM by
dividing the difference in slope (i.e. coefﬁcient of time * group
interaction effect) by the observed pre-treatment standard devia-
tion for thewhole group (Feingold, 2009).Within-group effect sizes
were based on observed values and calculated by dividing the
difference between the ﬁrst and second assessment with the
pooled within-group standard deviation (calculated using Equa-
tions (4.15) and (4.27) in Borenstein, Hedges, Higgins, & Rothstein,
2009).
Self-report measures were collected from both parents when
possible. When data from two parents were available the mean of
the parent ratings was used. Only the ICBT condition was assessed
at three-month follow-up, as participants in the waitlist condition
had been offered ICBT after completing the post-treatment
assessment.
Kappa coefﬁcients (Cohen, 1960) and intraclass correlation co-
efﬁcients (ICC; two-way random, average measure) was used to
calculate inter-rater reliability for composite ratings of anxiety
disorders at pre-treatment assessment, and for investigation of
agreement between child, parent and composite ratings on anxiety
disorders. The k values are evaluated as having poor reliabilityDirected
at
Parent
ation) and worry time/social skills training (only for GAD/Social phobia
Child
archies
n)
nd to report their progress in the platform
Parent
Child
Fig. 1. Screenshot of an animated psychoeducation ﬁlm from the program.
Fig. 2. Screenshot of an animated drag-and-drop exercise from the program.
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and excellent when k is > 0.74 (Mannuzza et al. 1989).3. Results
3.1. Descriptives
Participants were 93 children, aged 8e12 years, and 182 parents.
Ninety per cent of participants lived in Stockholm County. De-
mographic variables are presented in Table 2. In general, parents
were well educated with the majority having completed a univer-
sity degree. About a third of the children had a principal diagnosis
of separation anxiety or speciﬁc phobia, respectively and approxi-
mately 20% had a principal GAD diagnosis. Seventy per cent of the
children had more than one diagnosis, the average number of di-
agnoses being 2.3 (SD ¼ 1.3, Mdn ¼ 2). At pre-treatment, child
ratings of depression and parent ratings of their own anxiety and
depression symptomswere low (CDI; M¼ 6.6, SD¼ 4.9 and PRIME-
MD; M ¼ 5.5, SD ¼ 2.5, respectively).
Inter-rater reliability at pre-treatment was good (k ¼ 0.65,p < 0.01) for anxiety disorders (i.e., presence ‘‘yes’’ or ‘‘no’’) and
excellent for CSR scores of anxiety disorders (ICC ¼ 0.77). Overall,
CSR-scores on anxiety disorders from the child and parent inter-
view showed moderate correlations (r(91) ¼ 0.43e0.49, p < 0.01),
while there was a stronger correlation between anxiety disorder
CSR-scores from the parent interview and the composite scores
(r(91) ¼ 0.77e0.83, p < 0.01). Agreement on presence of anxiety
disorders between parent interview and composite scores were
good to very good (k¼ 0.72e0.82, p < 0.01). Agreement on presence
of anxiety disorders was lower between child- and parent-based
interviews (k ¼ 0.37e0.46, p < 0.01), and child and composite in-
terviews (k ¼ 0.56e0.68, p < 0.01).3.2. Missing data
CSR ratings were missing for three participants (3%) at post-
treatment and seven participants (15%) at three-month follow-up.
Self-assessments were completed by 73 children (78%) and 76
parents (82%) at post-treatment and 35 (76%) parents and children
in the treatment group at three-month follow-up (see Fig. 3). No
Table 2
Demographic and clinical information.
Total sample (N ¼ 93) ICBT (n ¼ 46) WL (n ¼ 47) p-value
Children females, n (%) 51.0 (55) 26 (57) 25 (54) 0.747
Age of children, M (SD) 10.1 (1.7) 10.3 (1.2) 9.9 (1.1) 0.109
Age of parents, M (SD) 43.1 (5.3) 42.8 (5.0) 43.4 (5.6) 0.483
Range 31e60 31e58 33e60
Parental education level, n (%) 0.377
9 years 6 (3) 5 (5.4) 1 (1.1)
12 years 34 (19) 19 (20.7) 15 (16.3)
Vocational education 14 (8) 6 (6.5) 8 (8.7)
Current university studies 6 (3) 2 (2.2) 4 (4.3)
University degree 124 (67) 60 (65.2) 64 (69.6)
Number of diagnoses, n (%) 0.648
1 30 (32) 15 (33) 15 (32)
2 27 (29) 14 (30) 13 (28)
3 21 (22) 10 (22) 11 (23)
4 8 (9) 4 (9) 4 (9)
>4 7 (8) 3 (7) 4 (9)
CDI score at baseline, M (SD) 6.6 (4.8) 6.8 (5.2) 6.3 (4.6) 0.632
Diagnoses, n (%) 0.918
GAD 20 (22) 11 (24) 9 (19)
Panic disorder 5 (5) 2 (4) 3 (6)
Separation anxiety 30 (32) 16 (35) 14 (30)
Social anxiety disorder 9 (10) 4 (9) 5 (11)
Speciﬁc phobia 29 (31) 13 (28) 16 (34)
Note: CDI¼ Children's Depression Inventory; GAD ¼ Generalised anxiety disorder; ICBT¼ Internet-delivered cognitive behavioural therapy; WL ¼ waitlist control.
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on CSR or SCAS (child and parent reported), age, gender, CDI,
principal diagnosis or number of diagnoses between children who
did and children who did not complete self-report measures at
post-treatment. Between families where at least one parent
completed measures at post-treatment and families where none of
the parents completed measures at post-treatment there were
signiﬁcant differences on the number of completed modules (with
families where at least one parent completed measures at post-
treatment completing more modules on average) (t (44) ¼ 2.04,
p¼ 0.048). Furthermore, there was a signiﬁcant difference between
families who did and did not participate in the ADIS interview at
three-month follow-up, with parents not participating having
higher post scores on the CSR and the SCAS-P.3.3. Treatment outcomes
Pre- and post-treatment assessments for both groups including
interaction effects and between-group effects are presented in
Table 3 together with the follow-up assessments for the treatment
group. Within-group effects sizes are presented for both groups in
Table 4.
The pre-to post-treatment change on the CSR, the primary
outcome, was signiﬁcantly larger in the treatment group than in the
waitlist group at post-treatment, with a large between-group effect
size of d ¼ 1.66. CSR in the treatment group showed additional
signiﬁcant decrease between post-treatment and 3-month follow-
up (t (38) ¼ 4.72, p < 0.001). The within-group effect size between
pre-treatment and follow-up was large (d ¼ 1.84) (see Table 4).
Nine (20%) participants in the treatment group no longer met
criteria for their principal diagnosis at post-treatment compared to
three (7%) in the waitlist group. These proportions did not signiﬁ-
cantly differ (x2 (1) ¼ 3.60, p ¼ 0.058). At three-month follow-up
the number had increased to 23 (50%) in the treatment group.
The pre-to post-treatment change on CGAS-ratings was signif-
icantly higher, indicating higher functioning, in the treatment
group than in the waitlist group at post-treatment. The between-
group effect size was small (d ¼ 0.45). An additional signiﬁcant
increase in ratings of functioning was seen between post-treatmentand three-month follow-up in the treatment group (t (38) ¼ 5.14,
p < 0.001) and the within-group effect size between pre-treatment
and three-month follow-up was large (d ¼ 1.24).
Parent-reported child anxiety, measured with SCAS-P, showed a
signiﬁcantly greater pre-to post-treatment change in the treatment
group compared to the waitlist group, with a small between-group
effect size (d ¼ 0.45). At three-month follow-up, the within-group
effect size, compared to pre-treatment had increased from d ¼ 0.66
to d ¼ 0.91 and there was a signiﬁcant decrease in ratings (t
(27)¼ 2.18, p < 0.038). Therewere no signiﬁcant differences on pre-
to post-treatment changes in SCAS-C between treatment and
waitlist group, although ratings dropped in both groups (within-
group effect size d¼ 0.51 and d¼ 0.56 in the treatment and waitlist
group, respectively). At three-month follow-up ratings had drop-
ped, compared to post-treatment, in the treatment group. How-
ever, the change was not statistically signiﬁcant (t (24) ¼ 1.93,
p < 0.065). No signiﬁcant group differences were found on pre-to
post-treatment changes on QOLI and no signiﬁcant difference was
seen between post-treatment and follow-up (t (24) ¼ 0.56,
p < 0.582) in the treatment group.
Diagnosis speciﬁc measures (child and parent versions of FSSC-
R, PSWQ, SAI or SPAI) did not reveal any signiﬁcant group differ-
ences on pre-to post-treatment changes. Due to a large amount of
missing data on these measures, test of maintenance of improve-
ment between post-treatment and FU was not conducted for the
speciﬁc measures. Detailed results are presented in Table S1
(available online).3.4. Treatment satisfaction
Of the 46 families randomised to ICBT, 32 children and 62 par-
ents completed the CSS. Overall, children and parents were
moderately satisﬁed with the treatment with a mean rating of 3.67
and 3.78 respectively. Parents rated item “I would recommend this
treatment” highest, with 86% indicating “Agree” or “Very much
agree” and item “My child is not more scared than other children
his/her age” the lowest, with only 31% indicating “Agree” or “Very
much agree”. Children rated item “This treatmentwas effective” the
highest with 82% responding “Agree” or “Very much agree”, and
Telephone 
interview 
n=170
Excluded n=29
Did not fulfill inclusion criteria: 
a=6, b=9 and d=1
Fulfilled exclusion criteria: 
a=6, c=4 and e=3
Post-treatment
Primary outcome n=45
Child report n=42
Parent report n=43
Waitlist
n=47
Excluded n=3
Did not fulfill inclusion criteria: 
b=3
Screening with 
DAWBA 
n=136
Self report 
questionnaires
n=122
Diagnostic 
Interview 
n=107
Excluded n=4
Fulfilled exclusion criteria: 
b=4
Excluded n=8
Did not fulfill inclusion criteria: 
b=5
Fulfilled exclusion criteria:
e=3
Randomized
N=93
ICBT
n=46
Post-treatment
Primary outcome n=45
Child report n=31
Parent report n=33
Three-month 
follow-up
Primary outcome n=39
Child report n=35
Parent report n=35
Families that did not 
participate at all n=0
Families that did not 
participate at all n=6
Withdrew/did not answer n=11
Withdrew/did not answer n=11
Withdrew/did not participate 
n=6
Withdrew n=5
Fig. 3. Participation ﬂow through the study.
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lowest, with only 44% responding “Agree” or “Very much agree”.
Results are presented in detail in Table S2 (available online).
3.5. Treatment compliance and further treatment seeking
Not all families completed all modules in the recommended
pace. The mean number of completed modules was 9.7 (SD ¼ 1.8;
range 4e11) and 83% completed the ﬁrst nine modules. Twenty-
nine participants (63%) completed at least one of the two mainte-
nance modules. Four families (9%) did not reach the modules that
were intended for both children and parents (starting with module
7). Number of characters written in the platform ranged from 1440to 24,408 (M ¼ 9666, SD ¼ 5663, Mdn ¼ 9084), which corresponds
to approximately 0.5e11 pages (M ¼ 4.4, SD ¼ 2.6, Mdn ¼ 4.13).
Linear regression showed that post-treatment CSR scores were not
signiﬁcantly predicted by number of completed modules
(Beta ¼ 0.169, t ¼ 1.12, p ¼ 0.268) or number of characters entered
in the platform (Beta ¼ 0.04, t ¼ 0.262, p ¼ 0.795). Although fam-
ilies were instructed to log in to the platform and report completed
exposure tasks, no families followed this recommendation in a
systematic way. No participants in the treatment group that
participated in follow-up assessment had sought help for the
child's anxiety problems elsewhere.
4. Discussion
The aim of the present study was to evaluate the efﬁcacy of ICBT
for children with anxiety disorders. On the primary outcome
measure, we found a large effect size in favour of the treatment
group at post-treatment and effects were maintained at three-
month follow-up. There was a small but signiﬁcant interaction ef-
fect of time and treatment on parent-rated anxiety at post-
treatment, but no signiﬁcant effects were observed on child-
ratings of anxiety.
CSR ratings showed a signiﬁcantly larger decrease in the treat-
ment group compared to the waitlist group at post-treatment, but
the mean CSR rating did not fall below four, which is the cut off for
clinical level of impairment and severity, until three-month follow-
up. The large between-groups effect on CSR was comparable to
March et al. (2009) although they reported a larger decrease of
absolute CSR scores at post-treatment and follow-up. March et al.
(2009) had a longer follow-up time and also included booster
sessions after one and three months, which could account for the
greater improvement (although only 41% of children completed the
booster sessions).
The proportion of participants no longer meeting criteria for
their principal diagnosis did not signiﬁcantly differ between groups
at post-treatment, the proportions being 20% and 7% in the treat-
ment and waitlist group, respectively. This was somewhat lower
thanwhat was seen inMarch et al. (2009) where the corresponding
proportions were 30% and 10%. March et al. also reported that 75%
no longer met criteria for their primary diagnosis at 6-month
follow-up. A review by James et al. (2013) found average remis-
sion rates for anxiety disorders after CBT to be 56%. Consistent with
ﬁndings in Vigerland et al. (2013), the treatment in the present
study seems to have a delay in treatment effect, reaching compa-
rable levels of remission (50%) at three-month follow-up. As this
effect was uncontrolled, it needs to be interpreted cautiously. Also,
there was a larger proportion of missing data at three-month
follow-up (15%), and analyses showed that participants with
missing follow-up data had signiﬁcantly higher CSR and SCAS-P
scores at post treatment than those who completed the follow-up
interview. This suggests that results on the CSR and on diagnostic
status in the observed sample may be a slight overestimation.
On the CGAS-ratings of global functioning, the small effect size
found in this study at post-treatment is considerably lower than in
March et al. (2009) and the absolute difference between pre- and
post-treatment scores was small.
No signiﬁcant treatment effect on child ratings of anxiety, SCAS-
C, was found in the present study. This is in line with March et al.
(2009), who reported no signiﬁcant treatment effects for levels of
child rated anxiety symptoms. Furthermore, other studies of CBT
for children with anxiety disorders have not found any signiﬁcant
between group treatment effect on the SCAS-C, and it may be that
the properties of the measure are not optimal for treatment eval-
uation (Spence et al., 2011; Spence, Holmes, March, & Lipp, 2006;
Wergeland et al., 2014). On SCAS-P, a small signiﬁcant treatment
Table 3
Treatment outcomes - Observed means and standard deviations for treatment- and waitlist group at pre-treatment, post-treatment and follow-up (for the treatment group).
Between-groups effect sizes based on the estimates obtained in the hierarchical linear mixed models are presented together with the coefﬁcient (Dslope) for the interaction
effect between time and study group.
Pre Post FU Between-group differences
n M SD n M SD n M SD In pre-to-post change [95% CI]
CSR
ICBT 46 5.7 0.7 45 4.4 1.2 39 3.3 1.6 Dslope 1.16 [0.77, 1.55]
WL 47 5.6 0.7 45 5.4 1.1 Effect size d 1.66 [1.18, 2.14]
CGASa
ICBT 46 55.2 4.7 45 58.1 4.4 39 61.3 5.1 Dslope 2.31 [1.43, 3.19]
WL 47 57.5 5.4 45 57.9 5.6 Effect size d 0.45 [0.03, 0.87]
SCAS-C
ICBT 46 35.9 13.7 31 29.0 13.6 35 25.5 16.3 Dslope 0.06 [4.45, 4.57]
WL 47 34.4 13.3 42 27.1 12.9 Effect size d <0.01 [0.47, 0.46]
SCAS-P
ICBT 46 32.5 9.3 33 25.7 11.2 35 22.7 12.0 Dslope 4.29 [7.81, 0.77]
WL 47 28.6 9.3 43 25.7 10.2 Effect size d 0.45 [0.01,0.9]
QOLIa
ICBT 46 4.1 1.1 31 3.7 1.4 35 3.9 1.1 Dslope 0.29 [0.75, 0.17]
WL 47 4.0 1.1 42 4.0 1.1 Effect size d 0.26 [0.72, 0.27]
Note: CDI¼ Children's Depression Inventory; CGAS¼ Children's Global Assessment Scale; CSR¼ Clinician Severity Rating; GAD ¼ Generalised anxiety disorder;
ICBT¼ Internet-delivered cognitive behavioural therapy; SCAS C/P¼ Spence Children's Anxiety Scale; QOLI ¼ Quality of Life Inventory; WL ¼ waitlist control.
a Higher scores indicate higher functioning. Sign of effect sizes have been changed so that positive scores indicate improvement.
Table 4
Within-group effect sizes.
Within-group effect sizes [95% CI]
Pre-post Pre-FU Post-FU
CSR
ICBT 1.32 [0.88, 1.76] 1.84 [1.19, 2.49] 0.70 [0.41,0.99]
WL 0.19 [0.03, 0.42]
CGASa
ICBT 0.63 [0.43, 0.83] 1.24 [0.84, 1.65] 0.67 [0.42,0.91]
WL 0.06 [0.0, 0.12]
SCAS-C
ICBT 0.51 [0.18, 0.84] 0.63 [0.13, 1.14] 0.18 [0.05,0.40]
WL 0.56 [0.35, 0.77]
SCAS-P
ICBT 0.66 [0.27, 1.05] 0.91 [0.39, 1.43] 0.26 [0.02,0.50]
WL 0.29 [0.11, 0.47]
QOLIa
ICBT 0.30 [0.03, 0.57] 0.21 [0.15, 0.56] 0.12 [0.42,0.17]
WL 0.02 [0.28, 0.33]
Note: CDI¼ Children's Depression Inventory; CGAS¼ Children's Global Assessment
Scale; CSR¼ Clinician Severity Rating; GAD ¼ Generalised anxiety disorder;
ICBT¼ Internet-delivered cognitive behavioural therapy; SCAS C/P¼ Spence Chil-
dren's Anxiety Scale; QOLI ¼ Quality of Life Inventory; WL ¼ waitlist control.
a Higher scores indicate higher functioning. Sign of effect sizes have been changed
so that positive scores indicate improvement.
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to March et al. (2009) where the corresponding effect size was
d ¼ 0.31.
Diagnosis speciﬁc measures showed no signiﬁcant effects at
post-treatment. This could partly be explained by a lack of power,
as there were few patients (9e29) in each diagnostic group and
quite a large number of missing data on these measures (11%e43%)
at post-treatment. On the child versions of the FSSC-R there was an
increase in the scores (indicatingmore fear) in the treatment group.
Questions on treatment satisfaction focused largely on
perceived treatment outcome and a majority of participants in the
treatment group rated the treatment as helpful. Indeed, 86 per cent
of parents indicated they would recommend the treatment to a
friend with similar problems. Overall, parents and children were
neutral or positive, which is in accordance with the moderate
treatment effects found at post-treatment.
While Spence et al. (2011) andWuthrich et al. (2012) are similarto the present study, with regard to the inclusion of children with
diagnosed anxiety disorders and the use of a CBT-programwith non
face-to-face therapist support, they were aimed at adolescents and
are therefore not completely comparable. Even so, results are
largely similar. Spence et al. (2011) and Wuthrich et al. (2012) both
showed a signiﬁcant between-group effect in favour of the treat-
ment group, compared to waitlist, and a large within-group effect
size on CSR ratings in the treatment group. Proportion of partici-
pants free of their principal anxiety disorder at post-treatment was
34% and 41% for Spence et al. and Wuthrich et al., respectively.
Spence et al. did not ﬁnd signiﬁcantly larger improvements for ICBT
on SCAS-C or SCAS-P compared to waitlist control, while Wuthrich
et al. found signiﬁcantly larger decreases in the treatment group
from pre-to post-treatment on SCAS-C and SCAS-P, with large
within-group effect sizes. Khanna and Kendall's (2010) evaluation
of computer-assisted CBT, including several therapist-led exposure
sessions, also showed results in favour of computer-assisted CBT on
CSR ratings compared to a computerised control intervention, but
no signiﬁcant differences on child ratings of anxiety.
In summary, treatment outcomes in the present study were not
substantially different from those in other, similar studies. The
somewhat weaker treatment outcomes seen in this study could be
associated with poor treatment engagement. Although a majority
of families completed all the psychoeducation there are no avail-
able data on number of exposures or amount of time that families
worked with the treatment outside of the computer. The experi-
ence of the psychologists in the study was that families understood
the concept of exposure, but did not practice exposure tasks to the
extent that was necessary.
Although the sample was relatively high-functioning with
baseline CSR- and CGAS-scores indicating less severity than seen in
for instance March et al. (2009) and Kendall et al. (2010), parent
ratings on SCAS-P showed levels of anxiety symptom consistent
with a clinical sample (Nauta et al., 2004). Moreover, a majority of
included children fulﬁlled criteria for at least two anxiety disorders,
indicating a clinical, if not a highly severe, sample.4.1. Limitations
The study has a number of limitations, which should be taken
into consideration when interpreting the results. First of all, the
S. Vigerland et al. / Behaviour Research and Therapy 76 (2016) 47e56 55primary outcome measure was not rated by blind assessors, but by
assessors that were aware of treatment allocation, and involved in
the project. It cannot be ruled out that this can have affected the
results. Also, CSR scores at post-treatment and follow-up were
based solely on parent information whereas they were based on
child- and parent report at pre-treatment. Limited resources
necessitated telephone interviews at post-treatment and follow-
up, and only parents were interviewed as some children were
considered too young to participate in a telephone interview. At
pre-treatment, diagnoses based only on parent interviews showed
good to excellent agreement with composite diagnoses, while
agreement between child based diagnoses and composite di-
agnoses was lower. This is in line with previous research that has
shown that clinicians are more inﬂuenced by parent report when
assigning diagnoses (Grills & Ollendick, 2003, Rapee, Barrett,
Dadds, & Evans, 1994). Together with results from Lyneham and
Rapee (2005), suggesting that relying only on information from
the parent can be sufﬁcient in determining presence or absence of
diagnoses, it suggests that results in this study might not have been
substantially different if child-report had been included in post-
treatment assessment. However, the results should be interpreted
cautiously.
Secondly, we used a waitlist-control and not an active control
group, and thus we did not control for effects of expectancy of
improvement or attention from a caregiver. In addition, there was
no control group at three-month follow-up and it cannot be ruled
out that the further improvement that was found in the treatment
groupwas due to passage of time or natural recovery rather than an
effect of treatment.
Furthermore, there are no valid data on treatment compliance.
The data that are available on number of completed stages might
not provide a fair description of participants’ activity. Unfortu-
nately, we have no data on amount of exposure, which we believe
to be the component that contributes mostly to positive treatment
outcome. Also, we believe that some participants would have
beneﬁted from a more regular contact with a supportive therapist.
Future trials should include a more regular interaction with the
treatment platform and contact with the therapist as a way of
increasing amount of exposure exercises, improving measurement
of treatment compliance and possibly improving effects.
Finally, this study does not include data on therapist time,
number of additional phone calls, length of phone calls or other
therapist variables. This should be addressed in future studies as it
could be important with regard to generalisability and cost-
effectiveness.
5. Conclusions
Although this study has some limitations, it supports previous
ﬁndings that ICBT with therapist support can reduce clinician- and
parent-rated symptoms of anxiety. However, there is still need to
better understand secondary outcomes, including child-ratings of
anxiety and quality of life, and to get more reliable estimates of
follow-up outcomes. Future studies should include blind assessors,
a larger sample and an active control group. If ICBT for childrenwith
anxiety disorders can prove its efﬁcacy and effectiveness in future
studies, it could be a way of making CBT more available for this
population.
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